Showing results (21-30 of 927) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|May 14, 2021
Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort studyRishi Caleyachetty, Thomas M Barber, Nuredin Ibrahim Mohammed, et al.
The Lancet. Diabetes & Endocrinology|May 11, 2020
Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgeryFrancesco Rubino, Ricardo V Cohen, Geltrude Mingrone, et al.
The Lancet. Diabetes & Endocrinology|May 22, 2015
Constructs of depression and distress in diabetes: time for an appraisalFrank J Snoek, Marijke A Bremmer, Norbert Hermanns
The Lancet. Diabetes & Endocrinology|May 22, 2015
The link between depression and diabetes: the search for shared mechanismsCalum D Moulton, John C Pickup, Khalida Ismail
The Lancet. Diabetes & Endocrinology|April 26, 2020
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trialDaisuke Yabe, Jiro Nakamura, Hideaki Kaneto, et al.
The Lancet. Diabetes & Endocrinology|April 26, 2020
Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trialsOlivia R Ghosh-Swaby, Shaun G Goodman, Lawrence A Leiter, et al.
The Lancet. Diabetes & Endocrinology|April 26, 2020
The importance of language in engagement between health-care professionals and people living with obesity: a joint consensus statementCharlotte Albury, W David Strain, Sarah Le Brocq, et al.
The Lancet. Diabetes & Endocrinology|May 22, 2021
Epidemiology and determinants of obesity in ChinaXiong-Fei Pan, Limin Wang, An Pan
The Lancet. Diabetes & Endocrinology|August 6, 2021
Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trialIan J Neeland, Steven P Marso, Colby R Ayers, et al.
The Lancet. Diabetes & Endocrinology|November 17, 2021
Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionalsKatarina Braune, Rayhan A Lal, Lenka Petruželková, et al.
Pageof 93